Removal Peripheral Intravenous Catheters According to Clinical Signs or Every 96 Hours: A Non Inferiority Study
NCT02568670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1305
Last updated 2018-03-21
Summary
This is a two-centers, open label, prospective, randomized, noninferiority controlled trial with cost-effectiveness analysis to verify if is non inferior to remove peripheral intravenous catheter according to clinical signs in relation to every 96 hours.
Conditions
- Phlebitis
Interventions
- OTHER
-
clinical signs
to remove the peripheral venous catheter according clinical signs
Sponsors & Collaborators
-
Federal University of São Paulo
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2016-08-31
- Completion
- 2016-09-30
Countries
- Brazil
Study Locations
More Related Trials
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Field Paramedic Application of Sepsis Triage
NCT03870789 ·Status: UNKNOWN
-
Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand
NCT02217592 ·Status: COMPLETED
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Fever Control Using External Cooling in Mechanically Ventilated Patients With Septic Shock
NCT04494074 ·Status: RECRUITING ·Phase: NA
-
I.M. Sechenov First Moscow State Medical University (Sechenov University)
NCT05319340 ·Status: COMPLETED ·Phase: NA
-
Heparin Anticoagulation in Septic Shock
NCT03378466 ·Status: TERMINATED ·Phase: PHASE2
-
Microcirculatory Oxygen Uptake in Sepsis
NCT02430142 ·Status: COMPLETED
-
Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.
NCT05572060 ·Status: UNKNOWN ·Phase: NA
-
Hemodynamic Evaluation Using Microcirculation for Early Treatment of Septic Patients
NCT06910891 ·Status: RECRUITING ·Phase: NA
-
Serial Body Composition Change for Risk Prediction and Nutritional Guide in Treating Patients With Sepsis
NCT04989569 ·Status: COMPLETED ·Phase: NA
-
Sepsis-3 Study in Northeast Thailand
NCT03379402 ·Status: COMPLETED
-
The Effect of Remote Ischemic Conditioning on the Microcirculation in Sepsis
NCT04644926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
NCT02654561 ·Status: RECRUITING ·Phase: PHASE3
-
Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock
NCT04870892 ·Status: UNKNOWN
-
Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis
NCT04644302 ·Status: COMPLETED
-
Mild Therapeutic Hypothermia During Severe Sepsis
NCT01069146 ·Status: COMPLETED ·Phase: NA
-
COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2
NCT01639664 ·Status: TERMINATED ·Phase: NA
-
Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063)
NCT02567305 ·Status: UNKNOWN
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS
NCT06063707 ·Status: NOT_YET_RECRUITING
-
In Vivo Antibiotics Removal During Hemoadsorption Cartridges and Continuous Renal Replacement Therapy in the Intensive Care Unit
NCT07230041 ·Status: RECRUITING
-
Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection
NCT04861922 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis
NCT02135770 ·Status: COMPLETED ·Phase: PHASE3
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA